Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1348, 2002-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risks and benefits of perioperative -blockers
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
Access to resources
Recommend
The US FDA is reviewing the safety of angiotensin receptor blockers (ARBs)
Reactions Weekly, Vol. 1, Iss. 1311, 2010-01 ,pp. :
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
Reviewing the management of HCV infection
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
Reviewing the management of endometriosis
Inpharma, Vol. 1, Iss. 1297, 2001-01 ,pp. :